BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24458221)

  • 1. UGT1A1*28 polymorphism in chronic lymphocytic leukemia: the first investigation of the polymorphism in disease susceptibility and its specific cytogenetic abnormalities.
    Karakosta M; Kalotychou V; Kostakis A; Pantelias G; Rombos I; Kouraklis G; Manola KN
    Acta Haematol; 2014; 132(1):59-67. PubMed ID: 24458221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.
    Ganster C; Neesen J; Zehetmayer S; Jäger U; Esterbauer H; Mannhalter C; Kluge B; Fonatsch C
    Genes Chromosomes Cancer; 2009 Sep; 48(9):760-7. PubMed ID: 19484764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 1 (PON1) Q192R and L55M Polymorphisms as Potential Predisposition Factors for Chronic Lymphocytic Leukemia.
    Ioannidou A; Zachaki S; Daraki A; Margariti IM; Pantelia D; Diamantopoulou P; Sambani C; Roussou P; Manola KN
    Anticancer Res; 2019 Jun; 39(6):2861-2869. PubMed ID: 31177124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
    Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
    Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.
    Glassman AB; Hayes KJ
    Cancer Genet Cytogenet; 2005 Apr; 158(1):88-91. PubMed ID: 15771912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia.
    Begleiter A; Hewitt D; Gibson SB; Johnston JB
    Leuk Res; 2009 Jan; 33(1):74-81. PubMed ID: 18676018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNR/11q#1 trinucleotide (GCC)n repeat alleles and predisposition to acute and chronic leukemia.
    Klinkov AA; Nikitin EA; Maiorova OV; Ivanov MA; Strelnikov VV; Babenko OV; Zemlyakova VV; Kuznetsova EB; Zaletayev DV
    Ann Hum Genet; 2004 Jul; 68(Pt 4):362-6. PubMed ID: 15225161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
    Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer.
    Bajro MH; Josifovski T; Panovski M; Jankulovski N; Nestorovska AK; Matevska N; Petrusevska N; Dimovski AJ
    Cancer Genet; 2012 Apr; 205(4):163-7. PubMed ID: 22559977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G; Kong Y; Yue C
    Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
    Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy 12 in B-cell chronic lymphocytic leukemia: interphase study by in situ hybridization in 75 patients.
    Coignet L; Berthéas MF; Vasselon C; Jaubert J; Reynaud J; Calmard-Oriol P; Brizard CP; Guyotat D
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):129-34. PubMed ID: 8332448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
    Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
    Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
    Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
    Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
    Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
    Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.